Tablet Coatings Market Size, Share, and Industry Analysis, By Coating Type (Film Coatings, Enteric Coatings, Controlled/Sustained-Release Coatings, Sugar Coatings, Specialty/Functional Coatings, and Others), By Polymer Type (Cellulosic, Acrylic, PVA/PEG, and Others), By Function (Immediate Release, Delayed Release and Sustained/Controlled Release), By End User (Pharma Manufacturers, Nutraceutical/Supplement Manufacturers, CMOs/CDMOs, and Others), and Regional Forecast 2026-2034

The tablet coatings market size was valued at USD 1.05 billion in 2025. The market is projected to grow from USD 1.11 billion in 2026 to USD 1.78 billion by 2034, exhibiting a CAGR of 6.1% during the forecast period.

The tablet coatings market is expected to grow significantly during the forecast period, driven by the expansion of the biopharmaceutical industry. The growing generics production and nutraceutical sector are fuelling market growth. Furthermore, amid soaring demand for biopharmaceuticals and, in turn, tablet coatings, many key companies are expanding their manufacturing capacity to meet rising market demand.

• For instance, in April 2025, Ashland expanded its pharmaceutical plant for Aquarius tablet coatings and commissioned new microbial protection capability in Brazil, demonstrating its strategy to increase production capacity and market presence.

Additionally, major companies are implementing technological advancements in their production facilities, utilizing innovative and safe materials, and forming key mergers and partnerships to strengthen their market position and support overall market growth.

Tablet Coatings Market Driver

Expansion of Biomanufacturing Capacity of Pharmaceuticals to Elevate Demand and Drive Market Growth

The expansion of biomanufacturing capacity in the pharmaceutical industry drives demand for tablet coatings, as manufacturers build more facilities or scale existing ones, thereby increasing overall drug production volumes. Growth in biomanufacturing capacity translates to more tablets and Biotherapeutics products being produced, resulting in elevated demand for tablet coating materials. This expanded production activity, therefore, directly boosts the market for tablet coatings as a necessary component of pharmaceutical manufacturing supply chains. Key companies are increasingly investing in new manufacturing facility expansions to cater to the growing market demand.

• For example, in July 2025, Colorcon inaugurated a new manufacturing facility in Johor, Malaysia, designed to enhance its production capabilities for film coatings. The facility spans 200,000 square feet and serves as a key production center for the Asia Pacific market.

Download Free sample to learn more about this report.

In December 2022, AAPS PharmSciTech published an article titled ‘Experimental Evaluation of the Impact of Rapid Environmental Changes on Stress Distribution in Tablet Coatings’ that reported the HPMC film carried 2–4× higher residual stress than the PVA film, with a median stress for HPMC of 6.88 MPa.

Tablet Coatings Market Restraint

High Cost of Microencapsulation to Hamper Market Growth

A key factor restraining market growth is the high cost of microencapsulation. Microencapsulation adds extra processing steps, requires specialized equipment, and tighter in-process controls, which raises manufacturing cost per tablet. Manufacturers must use higher-priced functional polymers, manage solvent- and temperature-sensitive operations, and validate more complex processes at scale, resulting in higher batch costs. These procedures further add to the cost. As a result, adoption is slower in cost-sensitive portfolios and emerging markets, and projects can be delayed when the added cost cannot be justified by reimbursement or pricing, which ultimately hampers market expansion.

• For instance, in February 2022, the International Journal of Pharmaceutical Research and Applications published a report on microencapsulation, which reported that the cost of materials used and the formulation process might be higher than those of standard formulations. Such factors hinder the market's growth.

Tablet Coatings Market Opportunity

Emergence of High-Performance Coating to Create a Major Growth Opportunity

A major growth opportunity for the global tablet coatings market lies in reformulating to next-generation, high-performance coatings, particularly titanium dioxide-free and other film coatings driven by regulatory or customer requirements. This presents an opportunity as regulators and brand owners push to remove or reduce certain ingredients to improve patient acceptability; manufacturers must redesign coating systems while still meeting requirements for opacity, stability, process efficiency, and appearance. That change forces both originators and generics to adopt newer coating chemistries and ready-to-use systems, which increases repeat purchasing of coating materials and technical services during scale-up and tech transfer. So, coating suppliers can grow by helping pharma companies switch more quickly without sacrificing quality or throughput.

Emphasizing these factors, many key companies are launching innovative coating systems to capitalize on this market opportunity, supporting market growth.

• For instance, in January 2025, Colorcon launched a new Opadry titanium dioxide (TiO2)-free film coating system for pharmaceutical tablets. This new formulation is not only TiO2-free but provides PVA-based coating benefits and good opacity at standard weight gain.

Segmentation

Key Insights

The report covers the following key insights:

• Key Industry Developments
• Overview: Advancements in Tablet Coatings
• New Product Launches, By Key Players
• Analysis: Emerging Application Areas for Tablet Coatings

Analysis by Coating Type

Based on the coating type, the global tablet coatings market is segmented into film coatings, enteric coatings, controlled/sustained-release coatings, sugar coatings, specialty/functional coatings, and others.

The film coatings segment is anticipated to hold a leading market share. Film coatings are the default choice for high-volume tablet production as they are faster to apply than other methods, use less material, scale well on modern coating equipment, and still deliver the core benefits. To capitalize on these factors, many key players are streamlining their resources to focus on new production capacity expansion with innovative features.  

• For instance, in April 2025, Kerry’s SheffCoat can accelerate production and optimize regulatory solutions for film coating development. Such developments are expected to lead to segmental growth.

Analysis by Polymer Type

Based on polymer type, the global tablet coatings market is segmented into cellulosic, acrylic, PVA/PEG, and others.

The cellulosic segment is anticipated to hold a leading market share. Cellulosic polymers, such as HPMC-based systems, are anticipated to dominate as regulators widely accept them and are compatible with many formulations. This enables manufacturers to adopt consistent processing on standard coating lines. Underscoring these advantages, key companies are investing in this polymer type and expanding production capacity.

• For instance, in March 2025, Shin-Etsu Chemical Co., Ltd. invested in two of its subsidiaries: SE Tylose GmbH & Co. KG and the Naoetsu Plant, to strengthen its pharmaceutical cellulose business. Such developments are expected to lead to segmental growth.

Analysis by Function

Based on function, the market is divided into immediate release, delayed release and sustained/controlled release.

Immediate release dominated the market. Immediate-release coatings are preferred as most tablets on the market are designed to deliver a fast therapeutic effect while keeping manufacturing simple and economical. As a result, coating demand is driven by everyday needs such as branding/appearance, basic protection, swallowability, and smoother production. This higher volume of conventional IR tablets directly translates into increased consumption of IR coating systems. Due to these factors, key companies are investing in advancing and enhancing their product offerings to promote adoption.

• For instance, in June 2025, Colorcon received the prestigious Market Impact Award at CPHI China 2025 for Opadry Complete Film Coating System. This recognition celebrated the company’s leadership in pharmaceutical film coatings and its commitment to innovation, quality, and customer trust. Such developments are expected to drive the segmental growth.

Analysis by End User

In terms of end-user, the market is divided into pharma manufacturers, nutraceutical/supplement manufacturers, CMOs/CDMOs, and others.

CMOs and CDMOS dominated the global market. Pharmaceutical companies are increasingly outsourcing the development and commercial manufacturing of oral solid doses to partners. These CDMOs have already validated their coating lines, trained their operators, and demonstrated proven quality systems. and can scale batches quickly, handle multiple formulations, and deliver consistent coating performance without requiring the sponsor to invest in new equipment or capacity. Emphasizing these factors, various CDMOs are expanding their manufacturing capacity. 

• For instance, in June 2024, Hovione, the specialist integrated CDMO, unveiled a continuous tableting (CT) line at its R&D Center in Lisbon. The new line was inaugurated in partnership with GEA. Such developments are expected to drive the segmental growth.

Regional Analysis

Request for Customization   to gain extensive market insights.

By region, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for approximately 40% of the global tablet coatings market in 2025. The growth of the market in the region is attributed to increasing funding initiatives that promote innovation in product offerings, thereby catering to market demand.  Hospitals continue to invest in ED-focused systems that reduce bottlenecks and adopt these solutions to comply with stricter guidelines set by regulatory bodies, supporting new federal data standards. These factors drive upgrades, integrations, and vendor partnerships that expand the capabilities of EDIS applications. Underscoring these factors, key companies operating in the market are also focusing on new product launches, underscoring their importance.

• For instance, in March 2024, Evonik made five generations healthier with EUDRAGIT coatings for targeted drug delivery. Evonik provided EUDRAGIT polymers as key ingredients in multi-component systems tailored to meet the unique and specific needs of individual customers—such developments are expected to fuel market growth.

Europe is expected to grow at a significant CAGR during the forecast period.  European health systems are expanding their biomanufacturing capacity and investing heavily to modernize their tablet coating capabilities, catering to the increasing demand.  The growing preference for oral tablets in the region supports market growth.

• For instance, in October 2025, Adare Pharma Solutions completed the expansion of its Pessano facility in Milan, Italy, significantly increasing the company’s European packaging & warehousing capacity. The line was designed for high-efficiency packaging of tablets and capsules into a wide range of formats. Such developments drive the market growth in the region.

Asia Pacific is expected to grow at a stable CAGR during the forecast period.  The region is experiencing growth in the market due to the increasing biopharmaceutical manufacturing activities in the area. With the rise of generics, key players in the region are investing in technological advancements to enhance their manufacturing capacity. These factors collectively drive growth in the region.

• For instance, in April 2025, Amcor completed construction of its advanced coating facility for healthcare packaging in Selangor, Malaysia. The state-of-the-art facility in Asia aimed to leverage cutting-edge air knife coating technology, strengthening the supply of high-quality, sterile packaging for healthcare customers across the region. Such developments are driving the region's growth.

Key Players covered

The global tablet coatings market reflects a semi-consolidated structure, with a few players capturing a significant market share.

The report includes the profiles of the following key players.

• Colorcon, Inc. (U.S.)
• Evonik Industries AG (Germany)
• BASF (Germany)
• Ashland (U.S.)
• Dow (U.S.)
• Shin-Etsu Chemical Co., Ltd. (Japan)
• Roquette Frères (France)
• Pfanstiehl, Inc. (U.S.)
• Ideal Cures Pvt. Ltd (India)
• Sensient Technologies Corporation (U.S.)

Key Industry Developments

• February 2025: Roquette launched a new coatings platform to meet the growing demand in prescription pharmaceutical, nutraceutical, and OTC markets. The platform offered one of the widest excipient portfolios on the market, with reliable, high-quality options to meet customers’ diverse needs, all in one place.
• April 2020: Upperton Pharma Solutions, a U.K.-based contract development and manufacturing organization (CDMO), invested USD 503.8 million to expand its tablet manufacturing capabilities.